Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies

A Multinational Survey of Risk Factors for Infection with Extended‐Spectrum β‐Lactamase–Producing Enterobacteriaceae in Nonhospitalized Patients

(2009) Ronen Ben‐Ami et al.   CLINICAL INFECTIOUS DISEASES

Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome

(2009) M. Ortega et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Incidence and clinical impact of extended-spectrum-β-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies

(2009) Enrico M. Trecarichi et al.   JOURNAL OF INFECTION

Prospective Study of Fecal Colonization by Extended-Spectrum- -Lactamase-Producing Escherichia coli in Neutropenic Patients with Cancer

(2008) L. Calatayud et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli

(2008) Jesús Rodríguez-Baño et al.   ARCHIVES OF INTERNAL MEDICINE

Faecal carriage of extended-spectrum  -lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology

(2008) J. Rodriguez-Bano et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern

(2008) Johann DD Pitout et al.   LANCET INFECTIOUS DISEASES